3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Leukemia, Biphenotypic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Leukemia, Myeloid, Accelerated Phase
3
Blast Crisis
3
Lymphoma, Mantle-Cell
2
Down Syndrome
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Specimen Handling
5
Nivolumab
4
Magnetic Resonance Spectroscopy
4
cabozantinib
3
Gemcitabine
3
enfortumab vedotin
2
Ipilimumab
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
trastuzumab deruxtecan
1
relatlimab
1
pembrolizumab
1
eribulin
1
erdafitinib
1
avelumab
1
atezolizumab
1
Lenalidomide
1
Doxorubicin
1
Contrast Media
1
Cisplatin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
merphos
×
90 days
×
Clear all
No trials found.